EIKOSpecialty Chemicals
Eiko Lifesciences Ltd — Balance Sheet
₹49.74
-3.48%
Eiko Lifesciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 1.39 Cr | 1.39 Cr | 0.96 Cr | 0.96 Cr | — |
| Share Issued | 1.39 Cr | 1.39 Cr | 0.96 Cr | 0.96 Cr | — |
| Total Debt | 2.76 Cr | 0.00 | 0.05 Cr | 4.63 Cr | — |
| Tangible Book Value | 56.79 Cr | 50.68 Cr | 29.42 Cr | 28.63 Cr | — |
| Invested Capital | 59.55 Cr | 50.68 Cr | 29.48 Cr | 33.26 Cr | — |
| Working Capital | 26.61 Cr | 29.42 Cr | 8.10 Cr | 6.43 Cr | — |
| Net Tangible Assets | 56.79 Cr | 50.68 Cr | 29.42 Cr | 28.63 Cr | — |
| Common Stock Equity | 56.79 Cr | 50.68 Cr | 29.42 Cr | 28.63 Cr | — |
| Total Capitalization | 58.80 Cr | 50.68 Cr | 29.42 Cr | 28.68 Cr | — |
| Total Equity Gross Minority Interest | 57.01 Cr | 50.68 Cr | 29.42 Cr | 28.63 Cr | — |
| Minority Interest | 0.22 Cr | — | — | — | — |
| Stockholders Equity | 56.79 Cr | 50.68 Cr | 29.42 Cr | 28.63 Cr | — |
| Other Equity Interest | 43.03 Cr | 37.81 Cr | 21.11 Cr | 20.31 Cr | — |
| Retained Earnings | 5.51 Cr | 3.40 Cr | 2.65 Cr | 1.86 Cr | — |
| Additional Paid In Capital | 37.52 Cr | 34.41 Cr | 18.46 Cr | 18.46 Cr | — |
| Capital Stock | 13.76 Cr | 12.87 Cr | 8.32 Cr | 8.32 Cr | — |
| Common Stock | 13.76 Cr | 12.87 Cr | 8.32 Cr | 8.32 Cr | — |
| Total Liabilities Net Minority Interest | 9.09 Cr | 2.06 Cr | 1.62 Cr | 6.26 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.83 Cr | 0.56 Cr | 0.42 Cr | 0.26 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.82 Cr | 0.56 Cr | 0.42 Cr | 0.20 Cr | — |
| Long Term Debt And Capital Lease Obligation | 2.01 Cr | 0.00 | 0.00 | 0.05 Cr | — |
| Long Term Debt | 2.01 Cr | 0.00 | 0.00 | 0.05 Cr | — |
| Current Liabilities | 6.27 Cr | 1.50 Cr | 1.20 Cr | 6.01 Cr | — |
| Other Current Liabilities | 1.79 Cr | 1000.00 | 0.05 Cr | 0.05 Cr | — |
| Current Debt And Capital Lease Obligation | 0.76 Cr | 0.00 | 0.05 Cr | 4.57 Cr | — |
| Current Debt | 0.76 Cr | 0.00 | 0.05 Cr | 4.57 Cr | — |
| Current Provisions | 0.17 Cr | 0.01 Cr | 0.05 Cr | 0.03 Cr | — |
| Payables | 3.75 Cr | 1.46 Cr | 1.09 Cr | 1.38 Cr | — |
| Other Payable | 0.08 Cr | 0.01 Cr | 0.02 Cr | 0.03 Cr | — |
| Total Tax Payable | 0.35 Cr | 0.07 Cr | 0.02 Cr | 57000.00 | — |
| Accounts Payable | 3.31 Cr | 1.38 Cr | 1.05 Cr | 1.35 Cr | — |
| Total Assets | 66.10 Cr | 52.74 Cr | 31.04 Cr | 34.89 Cr | — |
| Total Non Current Assets | 33.22 Cr | 21.82 Cr | 21.74 Cr | 22.46 Cr | — |
| Investmentin Financial Assets | 28000.00 | 4.02 Cr | 1.18 Cr | 5.87 Cr | — |
| Available For Sale Securities | 28000.00 | 4.02 Cr | 1.18 Cr | 5.87 Cr | — |
| Trading Securities | 0.00 | 0.00 | 0.00 | — | — |
| Long Term Equity Investment | 7.15 Cr | — | — | — | — |
| Investmentsin Associatesat Cost | 7.15 Cr | — | — | — | — |
| Net PPE | 23.12 Cr | 13.57 Cr | 13.88 Cr | 14.29 Cr | — |
| Accumulated Depreciation | -2.83 Cr | -2.12 Cr | -1.46 Cr | -0.83 Cr | — |
| Gross PPE | 25.95 Cr | 15.69 Cr | 15.34 Cr | 15.12 Cr | — |
| Other Properties | 9.41 Cr | 0.49 Cr | 0.49 Cr | 0.45 Cr | — |
| Machinery Furniture Equipment | 8.34 Cr | 8.48 Cr | 8.24 Cr | 8.07 Cr | — |
| Buildings And Improvements | 5.34 Cr | 3.86 Cr | 3.83 Cr | 3.81 Cr | — |
| Land And Improvements | 2.86 Cr | 2.86 Cr | 2.79 Cr | 2.79 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 32.88 Cr | 30.93 Cr | 9.30 Cr | 12.44 Cr | — |
| Other Current Assets | 24000.00 | 1.06 Cr | 0.68 Cr | 1.97 Cr | — |
| Prepaid Assets | 4.53 Cr | 1.06 Cr | 0.68 Cr | 2.20 Cr | — |
| Inventory | 5.77 Cr | 3.39 Cr | 0.91 Cr | 5.46 Cr | — |
| Finished Goods | 4.21 Cr | 1.80 Cr | 0.03 Cr | 1.20 Cr | — |
| Work In Process | 0.05 Cr | 0.08 Cr | 0.06 Cr | 1.32 Cr | — |
| Raw Materials | 1.51 Cr | 1.50 Cr | 0.82 Cr | 2.94 Cr | — |
| Accounts Receivable | 10.79 Cr | 13.13 Cr | 7.11 Cr | 4.56 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 11.78 Cr | 13.35 Cr | 0.61 Cr | 0.22 Cr | — |
| Cash And Cash Equivalents | 11.78 Cr | 13.35 Cr | 0.61 Cr | 0.22 Cr | — |
| Cash Equivalents | 7.24 Cr | 11.92 Cr | 0.01 Cr | 0.01 Cr | — |
| Cash Financial | 4.54 Cr | 1.43 Cr | 0.60 Cr | 0.21 Cr | — |
| Other Non Current Assets | — | 1000.00 | — | — | — |
| Restricted Cash | — | — | 0.00 | 0.00 | 3.87 Cr |
| Net Debt | — | — | — | 4.41 Cr | 1.56 Cr |
| Other Non Current Liabilities | — | — | — | -2000.00 | -1.00 |
| Non Current Deferred Taxes Assets | — | — | — | 0.00 | 0.02 Cr |
| Other Receivables | — | — | — | 0.01 Cr | 36000.00 |
| Taxes Receivable | — | — | — | 0.38 Cr | 0.39 Cr |
| Other Short Term Investments | — | — | — | 0.23 Cr | 2.47 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Eiko Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.